Why the study?
Does an acute elevation of arterial free fatty acids affect myocardial oxygen consumption in intact, anesthetized dogs?
Does an acute elevation of arterial free fatty acids affect myocardial oxygen consumption in intact, anesthetized dogs?
Answers are grounded in this paper and cite their sources.
Acute elevation of arterial free fatty acids within the physiologic range does not significantly alter myocardial oxygen consumption in an intact canine model.
Myocardial oxygen consumption (MyO₂) was measured in intact, anesthetized dogs prior to and during an acute elevation of arterial free fatty acids (FFA). FFA were elevated by the infusion of a lipid emulsion (‘Intralipid’) coupled with heparin to intensify lipolysis. Intralipid infusion prior to heparin (n = 7) caused a small increase in FFA (352 ± 41–666 ± 67 µEq/l) without significant change in either MyO₂ or hemodynamics. Following heparin, arterial FFA rose from a base line, preheparin level of 649 ± 50–1,925 ± 186 µEq/l at 10 min, 1,988 ± 247 µEq/l at 20 min, and 1,750 ± 221 µ./Eq/l at 30 min. Hemodynamics were essentially stable throughout the study. No significant change was observed in either MyO₂ or mean coronary blood flow, while myocardial oxygen extraction showed a small but significant increase at 10 and 30 min. An acute elevation of arterial FFA within the physiologic range does not significantly affect myocardial oxygen consumption in the intact, closed-chest anesthetized dog.
No takes yet. Share an insight, caveat, or question.
Most et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: